par Pellegrino, Benedetta;Tommasi, Chiara O.;Cursio, Olga Elisabetta;Musolino, Antonino;Migliori, Edoardo 
;De Silva, Pushpamali;Senevirathne, Thilini Hemali;Schena, Marina;Scartozzi, Mario;Farci, Daniele;Willard-Gallo, Karen ;Solinas, Cinzia
Référence Seminars in oncology, 48, 3, page (208-225)
Publication Publié, 2021-06-01
;De Silva, Pushpamali;Senevirathne, Thilini Hemali;Schena, Marina;Scartozzi, Mario;Farci, Daniele;Willard-Gallo, Karen ;Solinas, Cinzia Référence Seminars in oncology, 48, 3, page (208-225)
Publication Publié, 2021-06-01
Article révisé par les pairs
| Titre: |
|
| Auteur: | Pellegrino, Benedetta; Tommasi, Chiara O.; Cursio, Olga Elisabetta; Musolino, Antonino; Migliori, Edoardo; De Silva, Pushpamali; Senevirathne, Thilini Hemali; Schena, Marina; Scartozzi, Mario; Farci, Daniele; Willard-Gallo, Karen; Solinas, Cinzia |
| Informations sur la publication: | Seminars in oncology, 48, 3, page (208-225) |
| Statut de publication: | Publié, 2021-06-01 |
| Sujet CREF: | Hématologie |
| Cancérologie | |
| Mots-clés: | Breast cancer |
| Immune checkpoint blockade | |
| Immune checkpoint molecules | |
| Immunotherapy | |
| PD-1/PD-L1 | |
| Triple negative breast cancer | |
| tumor-infiltrating lymphocytes | |
| Note générale: | SCOPUS: re.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0093-7754 |
| info:doi/10.1053/j.seminoncol.2021.09.002 | |
| info:pii/S0093775421000543 | |
| info:scp/85118558780 | |
| info:pmid/34620502 |
